跳至主要内容
临床试验/NCT07351136
NCT07351136尚未招募不适用

Novel Diagnostic and Prognostic Predictors in Fabry Cardiomyopathy: Proof of Concept in a Rare Disease

Núcleo de Apoio à Investigação Clínica - FMUP0 个研究点目标入组 20 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

In this work, we address the understanding of the signaling pathways involved in cardiac remodeling in human SCD through molecular imaging analysis with a fibrosis marker. Furthermore, we emphasize characterizing the cardiac remodeling process by analyzing proteomic data from SCD myocardial biopsies and by analyzing the profile of microRNAs associated with hypertrophic cardiomyopathy and their diagnostic and prognostic value.

详细描述

The objective of this work is to explore the cardiac PET/CT imaging characteristics of cardiac fibroblast activation protein inhibitor (FAPI) and its relationship with the risk of sudden cardiac death (SCD) associated with myocardial fibrosis in SCD.

We also aim to deepen our understanding of the signaling pathways involved in SCD cardiac remodeling by comparing imaging data with proteomic and microRNA data.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients, over 18 years of age;
  • Diagnosis of Fabry disease

排除标准

  • Refusal to participate in the study

研究者

发起方
Núcleo de Apoio à Investigação Clínica - FMUP
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Núcleo de Apoio à Investigação Clínica - FMUP

Elisabete Martins

Universidade do Porto

相似试验